Published on 12/30/2019 in the Prospect News Structured Products Daily.
New Issue: HSBC prices $1.05 million autocallable barrier notes linked to biotech ETF, S&P 500
By Angela McDaniels
Tacoma, Wash., Dec. 30 – HSBC USA Inc. priced $1.05 million of 0% autocallable barrier notes with step-up premium due Jan. 2, 2024 linked to the S&P 500 index and the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be automatically called at par plus a call premium of 11.4% per year if each underlying closes at or above its call level, 90% of its initial level, on any annual observation date.
If the final return of the lesser-performing underlying is less than negative 10% – and therefore the notes are not called – but greater than or equal to negative 30%, the payout at maturity will be par. Otherwise, investors will lose 1% for every 1% that the lesser-performing underlying’s final level is less than its initial level.
HSBC Securities (USA) Inc. is the underwriter.
Issuer: | HSBC USA Inc.
|
Issue: | Autocallable barrier notes with step-up premium
|
Underlyings: | S&P 500 index and SPDR S&P Biotech ETF
|
Amount: | $1,048,000
|
Maturity: | Jan. 2, 2024
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | If final return of lesser-performing underlying is less than negative 10% but greater than or equal to negative 30%, par; otherwise, 1% loss for every 1% that lesser-performing underlying’s final level is less than initial level
|
Call: | Automatically at par plus call premium of 11.4% per year if each underlying closes at or above call level, 90% of initial level, on any annual observation date
|
Initial levels: | 3,221.22 for index and $96.70 for ETF
|
Barrier value: | 2,254.854 for index and $67.69 for ETF, or 70% of initial levels
|
Pricing date: | Dec. 20
|
Settlement date: | Dec. 30
|
Agent: | HSBC Securities (USA) Inc.
|
Fees: | 2%
|
Cusip: | 40435UN67
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.